Early cardiorenal risk is molecularly evidenced in hypertensive subjects within the normoalbuminuria condition. Novel glycotargets for cardiovascular risk stratification. (August 2022) - Santiago-Hernandez, A.; Martin-Lorenzo, M.; Gomez-Serrano, M.; Lopez, J.A.; Martinez, P.J.; Vazquez, J.; Ruiz-Hurtado, G.; Barderas, M.G.; Segura, J.; Ruilope, L.M.; Alvarez-Llamas, G.